Skip to content

Medical-device intelligence

Luminex Corporation: FDA clearances and recalls

Research Luminex Corporation in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

15 clearance records and 41 recall records in the covered releases, across 1 source company names and 18 product codes. Dated history runs from May 24, 2011 to Oct 5, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202610
June 202600
July 202600
August 202600
September 202600
October 202601

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

56 matching records
Device / recordCompany in FDA recordSourceSource date
LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303Z-0359-2027 · NSULuminex CorporationRecallNov 5, 2026FDA classification date
LIAISON PLEX Gastrointestinal Flex AssayK253722 · PCHLuminex Corporation510(k)May 19, 2026FDA decision date
LIAISON PLEX Gram-Positive Blood Culture AssayK243490 · PAMLuminex Corporation510(k)Jun 6, 2025FDA decision date
VERIGENE Gram Negative Blood Culture (BC-GN) Nucleic Acid Test, REF 20-006-021; for use with the sample-to-results VERIGENE System; invitro diagn…Z-1903-2025 · PENLuminex CorporationRecallJun 3, 2025FDA classification date
LIAISON PLEX Gram-Negative Blood Culture AssayK243013 · PENLuminex Corporation510(k)Apr 18, 2025FDA decision date
Verigene Gram Positive Blood Culture (BC-GP) Nucleic Acid TestZ-2533-2024 · PAMLuminex CorporationRecallAug 8, 2024FDA classification date
LIAISON PLEX Yeast Blood Culture AssayK240627 · PEOLuminex Corporation510(k)Jun 4, 2024FDA decision date
LIAISON PLEX Respiratory Flex AssayK233410 · QOFLuminex Corporation510(k)Mar 1, 2024FDA decision date
Luminex VERIGENE BC-GP Utility Tray (5-Pack Carrier), Gram-Positive Blood Culture Nucleic Acid Test, REF 20-011-018, a component of the Luminex V…Z-0500-2024 · PAMLuminex CorporationRecallDec 6, 2023FDA classification date
Verigene Enteric Pathogens Nucleic Acid Test (EP), REF 30-002-023Z-2023-2023 · PCHLuminex CorporationRecallJun 28, 2023FDA classification date
VERIGENE Clostridium difficile Nucleic Acid Test, REF 30-002-022Z-2024-2023 · OZNLuminex CorporationRecallJun 28, 2023FDA classification date
ARIES SARS-CoV-2 Assay, REF: 50-10047Z-0134-2023 · QJRLuminex CorporationRecallOct 26, 2022FDA classification date
ARIES SARS-CoV-2 AssayZ-1524-2022 · QJRLuminex CorporationRecallAug 17, 2022FDA record creation date
Verigene CDF Nucleic Acid Test, Part No. 30-002-22Z-1334-2022 · OZNLuminex CorporationRecallJul 6, 2022FDA record creation date
VERIGENE Enteric Pathogens Nucleic Acid Test, Part No. 30-002-23Z-1335-2022 · PCHLuminex CorporationRecallJul 6, 2022FDA record creation date
VERIGENE Nucleic Acid Test Kit-BC-GN Extraction Tray - 9.73 mL, REF 20-009-021Z-1109-2022 · PEPLuminex CorporationRecallMay 17, 2022FDA record creation date
Verigene Processor SP, Models 10-0000-07/10-0000-07R a component of the Verigene systemZ-1092-2022 · OOILuminex CorporationRecallMay 13, 2022FDA classification date
Verigene Processor SP, Model Numbers: 10-0000-07 and 10-0000-07-RZ-0920-2022 · NSULuminex CorporationRecallApr 13, 2022FDA record creation date
ARIES HSV 1&2 Assay, Catalog/REF# 50-10017Z-0553-2022 · OOILuminex CorporationRecallFeb 2, 2022FDA record creation date
ARIES HSV 1&2 Assay, Part Number/REF 50-10017Z-0498-2022 · OOILuminex CorporationRecallJan 14, 2022FDA record creation date
Verigene EP Amplification Reagent Kit TestZ-2451-2021 · PCHLuminex CorporationRecallSep 10, 2021FDA record creation date
Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) Model Number: 20-006-024Z-2006-2021 · OCCLuminex CorporationRecallJul 2, 2021FDA record creation date
Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) Model Number: 20-006-018Z-2007-2021 · OCCLuminex CorporationRecallJul 2, 2021FDA record creation date
Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN) Model Number: 20-006-021Z-2008-2021 · OCCLuminex CorporationRecallJul 2, 2021FDA record creation date
Verigene Enteric Pathogens Nucleic Acid Test (EP) Model Number: 20-006-023Z-2009-2021 · OCCLuminex CorporationRecallJul 2, 2021FDA record creation date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗